PharmaVOICE - 
April 2012
Purchase Issue

In Every Issue
Last Word
The Promise of Stem Cell Therapies for Chronic Diseases Andrew [...]
By

Dr. Andrew Pecora, Chief Medical Officer and Director at Neostem

Talent Pool
executive appointments and promotions in the healthcare industry By Carolyn [...]
By

Carolyn Gretton

PharmaTrax
Sales, marketing, And R&D?Trends affecting the healthcare industry Study Explores [...]
By

Carolyn Gretton

Social Media
Social Media trends, regs, and apps By Robin Robinson AstraZeneca [...]
By

Robin Robinson

Tools of the Trade
New electronic and web-based applications, sites, and technologies By Carolyn [...]
By

Carolyn Gretton

What’s New
New healthcare-related products, services, and companies Transparency Life Sciences Launches [...]
By

Carolyn Gretton

UpFront
Upfront Awards… CSL Honored for Work in Rare Diseases CSL [...]
By

Taren Grom, Editor

Letter from the Editor
The forum for the industry executive Volume 12 • Number [...]
By

Taren Grom, Editor

On The Cover

Competitive Intelligence and Strategy in Today’s Environment
s the industry experiences a myriad of new pressures, many of its tried-and-true business practices are shifting to meet new challenges, and the world of competitive intelligence (CI) is no exception. Some in the industry are predicting that not only will CI soon be defined differently, but its role and influence are also evolving. The [...]
By

Robin Robinson

Features

Five Keys to Successful Medical Affairs Innovation
Contributed by Jim Mercante, Sr. Vice President, Innovation, TGaS ­Advisors, a division of KnowledgePoint360 One of the best ways to attract, motivate and retain high-energy people with talent, ingenuity, drive and enthusiasm is to develop a culture focused on innovation excellence. An essential aspect of this culture at today’s leading pharma companies is the ability [...]
By

Jim Mercante, Sr. Vice President, Innovation, Tgas Advisors, a division of KnowledgePoint360

Maximizing the Value of Medical Affairs in Today’s Changing Environment
This is truly an exciting time for our colleagues in medical affairs. Following two to three years of shifts in responsibilities and funding for projects, it is now time to reassess the possibilities. The whole of medical affairs is positioned to become a designing factor in the future of compound development, scientific communications and improved [...]
By

Mary Anderson, President of SCI Scientific Communications & Information and Ogilvy CommonHealth Medical Education

SHOWCASE FEATURE: Medical Affairs: A Bridge to Better Outcomes
SHOWCASE FEATURE: MEDICAL AFFAIRS A Bridge to Better Outcomes By Carolyn Gretton The medical affairs organization within pharmaceutical, biotech, and device companies has moved beyond its traditional support role, evolving into a global group that provides a critical conduit between a wide range of internal stakeholders and the external clients they serve. “Medical affairs is [...]
By

Carolyn Gretton

SHOWCASE FEATURE: IRBs: Remaking the Rules
By Carolyn Gretton Institutional review boards (IRBs) and research compliance offices remain at the forefront of providing responsible protection of human subjects within the research environment, but the differences in how each group interprets and implements these responsibilities can directly affect the function of both entities. “Before the start of any study, we provide the [...]
By

Carolyn Gretton

Global Patient Recruitment
Robin Robinson Social media, regulations, and outsourcing are shaping global trial recruitment models. According to a recent CEI ­survey, more than 20% of ­responding companies use text messaging for patient visit ­reminders in Phase I through Phase III. Source: Cutting Edge Information As is true in almost every sector of the world, social media and [...]
By

Taren Grom, Editor

C-Suite Digital/Interactive Agencies
A staggering 4.8 trillion display ad impressions were delivered across the U.S. web in 2011 as brand advertisers continued to shift dollars to the digital medium. According to a recent comScore report, U.S. Digital Future in Focus 2012, the shift in ad dollars has magnified the need for greater transparency and accountability in ad delivery [...]
By

Taren Grom, Editor

France Puts Health on the Map
France is renowned for the quality of its healthcare ­system, competitive R&D ­environment, and worldwide translational medicine centers of excellence in several ­disease states. By Kim Ribbink France is a leading light in the area of healthcare and pharmaceuticals. Today, France is the second largest European country with 65 million people, just behind Germany with [...]
By

Kim Ribbink

Clinical Trial Technology Continues to Evolve
By Denise Myshko Electronic processes for data collection are now widely used in clinical trials. But the use of technology and electronic processes for the operational side of trials is still ­lagging. Ten years ago, when PharmaVOICE first started writing about clinical trial technologies, electronic data capture (EDC) was expected to be the magic bullet [...]
By

Denise Myshko

Patient Communities: Getting to Know You
Patient Communities: Getting to Know You By Robin Robinson The industry is tapping into the wealth of market research available through patient communities. In 2010, UCB and PatientsLikeMe launched a patient community designed as an online forum for epilepsy patients to share their experiences in order to, hopefully, improve their own personal disease management. UCB [...]
By

Robin Robinson

FEEDBACK